Crinetics Pharmaceuticals Statistics

Total Valuation

CRNX has a market cap or net worth of $4.43 billion. The enterprise value is $3.39 billion.

Market Cap	4.43B
Enterprise Value	3.39B

Important Dates

The last earnings date was Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

CRNX has 94.89 million shares outstanding. The number of shares has increased by 24.75% in one year.

Current Share Class	94.89M
Shares Outstanding	94.89M
Shares Change (YoY)	+24.75%
Shares Change (QoQ)	+0.45%
Owned by Insiders (%)	1.46%
Owned by Institutions (%)	109.41%
Float	87.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2,885.08
Forward PS	119.66
PB Ratio	4.12
P/TBV Ratio	4.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2,205.51
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.12, with a Debt / Equity ratio of 0.05.

Current Ratio	15.12
Quick Ratio	14.73
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -44.42% and return on invested capital (ROIC) is -29.76%.

Return on Equity (ROE)	-44.42%
Return on Assets (ROA)	-28.00%
Return on Invested Capital (ROIC)	-29.76%
Return on Capital Employed (ROCE)	-42.59%
Revenue Per Employee	$3,513
Profits Per Employee	-$968,185
Employee Count	437
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.28% in the last 52 weeks. The beta is 0.20, so CRNX's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	-18.28%
50-Day Moving Average	43.24
200-Day Moving Average	34.61
Relative Strength Index (RSI)	61.48
Average Volume (20 Days)	1,424,810

Short Selling Information

The latest short interest is 15.92 million, so 16.78% of the outstanding shares have been sold short.

Short Interest	15.92M
Short Previous Month	13.54M
Short % of Shares Out	16.78%
Short % of Float	18.15%
Short Ratio (days to cover)	10.84

Income Statement

In the last 12 months, CRNX had revenue of $1.54 million and -$423.10 million in losses. Loss per share was -$4.54.

Revenue	1.54M
Gross Profit	-312.04M
Operating Income	-477.85M
Pretax Income	-423.10M
Net Income	-423.10M
EBITDA	-474.16M
EBIT	-477.85M
Loss Per Share	-$4.54

Full Income Statement

Balance Sheet

The company has $1.09 billion in cash and $49.14 million in debt, giving a net cash position of $1.04 billion or $10.99 per share.

Cash & Cash Equivalents	1.09B
Total Debt	49.14M
Net Cash	1.04B
Net Cash Per Share	$10.99
Equity (Book Value)	1.07B
Book Value Per Share	11.34
Working Capital	1.05B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$347.67 million and capital expenditures -$6.33 million, giving a free cash flow of -$354.00 million.

Operating Cash Flow	-347.67M
Capital Expenditures	-6.33M
Free Cash Flow	-354.00M
FCF Per Share	-$3.73

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-31,130.16%
Pretax Margin	-27,563.32%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRNX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.75%
Shareholder Yield	-24.75%
Earnings Yield	-9.55%
FCF Yield	-7.99%

Analyst Forecast

The average price target for CRNX is $71.00, which is 52.13% higher than the current price. The consensus rating is "Buy".

Price Target	$71.00
Price Target Difference	52.13%
Analyst Consensus	Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	257.33%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CRNX has an Altman Z-Score of 15.73 and a Piotroski F-Score of 3.

Altman Z-Score	15.73
Piotroski F-Score	3